- Home
- NVNO vs CNF Comparison
NVNO vs CNF Comparison
Compare NVNO & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNO
- CNF
- Stock Information
- Founded
- NVNO 1987
- CNF 1999
- Country
- NVNO United States
- CNF China
- Employees
- NVNO N/A
- CNF N/A
- Industry
- NVNO Medical/Dental Instruments
- CNF Finance: Consumer Services
- Sector
- NVNO Health Care
- CNF Finance
- Exchange
- NVNO Nasdaq
- CNF Nasdaq
- Market Cap
- NVNO 41.0M
- CNF 36.9M
- IPO Year
- NVNO N/A
- CNF 2018
- Fundamental
- Price
- NVNO $3.51
- CNF $0.43
- Analyst Decision
- NVNO
- CNF
- Analyst Count
- NVNO 0
- CNF 0
- Target Price
- NVNO N/A
- CNF N/A
- AVG Volume (30 Days)
- NVNO 80.1K
- CNF 125.1K
- Earning Date
- NVNO 07-30-2025
- CNF 04-30-2025
- Dividend Yield
- NVNO N/A
- CNF N/A
- EPS Growth
- NVNO N/A
- CNF N/A
- EPS
- NVNO N/A
- CNF 0.08
- Revenue
- NVNO N/A
- CNF $85,661,735.00
- Revenue This Year
- NVNO N/A
- CNF $252.34
- Revenue Next Year
- NVNO $409.09
- CNF N/A
- P/E Ratio
- NVNO N/A
- CNF $5.32
- Revenue Growth
- NVNO N/A
- CNF N/A
- 52 Week Low
- NVNO $2.03
- CNF $0.37
- 52 Week High
- NVNO $6.48
- CNF $2.84
- Technical
- Relative Strength Index (RSI)
- NVNO 52.54
- CNF 27.49
- Support Level
- NVNO $3.26
- CNF $0.65
- Resistance Level
- NVNO $3.81
- CNF $0.75
- Average True Range (ATR)
- NVNO 0.26
- CNF 0.06
- MACD
- NVNO -0.04
- CNF -0.02
- Stochastic Oscillator
- NVNO 33.78
- CNF 15.84
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
About CNF CNFinance Holdings Limited each representing twenty (20)
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, it has an operation in PRC.